Description
Identification of cell types selectively vulnerable in neurodegenerative (AD, PD, ALS, FTD) and neuropsychiatric diseases using single-cell approaches. Includes SEA-AD, cell-type-specific transcriptomic changes, and selective neuronal loss patterns. | Gap: Causal direction between cell-type vulnerability and disease onset is unclear; early-stage disease cell-type changes are undersampled.